A detailed history of Synovus Financial Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Synovus Financial Corp holds 104,297 shares of RPRX stock, worth $2.53 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
104,297
Previous 104,297 -0.0%
Holding current value
$2.53 Million
Previous $2.95 Million -0.0%
% of portfolio
0.03%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$25.63 - $29.27 $3.03 Million - $3.46 Million
-118,379 Reduced 53.16%
104,297 $2.95 Million
Q2 2024

Aug 13, 2024

BUY
$26.26 - $29.9 $2.94 Million - $3.35 Million
111,918 Added 101.05%
222,676 $5.87 Million
Q1 2024

May 14, 2024

SELL
$27.46 - $31.33 $246,673 - $281,437
-8,983 Reduced 7.5%
110,758 $3.36 Million
Q3 2023

Nov 13, 2023

BUY
$26.26 - $31.38 $649,173 - $775,744
24,721 Added 26.02%
119,741 $3.25 Million
Q2 2023

Aug 08, 2023

SELL
$29.6 - $36.56 $122,810 - $151,687
-4,149 Reduced 4.18%
95,020 $2.92 Million
Q1 2023

May 11, 2023

BUY
$32.77 - $39.4 $202,321 - $243,255
6,174 Added 6.64%
99,169 $3.57 Million
Q4 2022

Feb 06, 2023

BUY
$39.17 - $44.04 $61,340 - $68,966
1,566 Added 1.71%
92,995 $3.68 Million
Q3 2022

Oct 27, 2022

BUY
$39.88 - $44.65 $68,473 - $76,664
1,717 Added 1.91%
91,429 $3.68 Million
Q2 2022

Aug 10, 2022

BUY
$37.53 - $44.22 $325,122 - $383,077
8,663 Added 10.69%
89,712 $3.77 Million
Q1 2022

May 12, 2022

SELL
$37.46 - $42.44 $104,925 - $118,874
-2,801 Reduced 3.34%
81,049 $3.16 Million
Q4 2021

Feb 14, 2022

BUY
$35.17 - $42.48 $2.95 Million - $3.56 Million
83,850 New
83,850 $3.34 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.